CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands |
Total |
Common Stock |
Additional Paid-In Capital |
Retained Earnings (Accumulated Deficit) |
Total Shareholders’ Equity |
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Common stock, shares issued (in shares) |
|
290,646,000
|
|
|
|
| Balance at beginning of period at Dec. 31, 2020 |
|
$ 29
|
$ 3,004,433
|
$ (400,501)
|
$ 2,603,961
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Restricted stock forfeited (in shares) |
|
(1,000)
|
|
|
|
| Restricted stock used for tax withholding (in shares) |
|
(128,000)
|
|
|
|
| Restricted stock used for tax withholding |
|
|
(477)
|
|
(477)
|
| Issuance of Common Stock under Employee Stock Purchase Plan |
|
276,000
|
|
|
|
| Issuance of Common Stock under Employee Stock Purchase Plan |
|
|
167
|
|
167
|
| Stock-based compensation - equity awards |
|
|
4,585
|
|
4,585
|
| Capped call premiums |
|
|
(14,688)
|
|
(14,688)
|
| Net income (loss) |
|
|
|
(34,645)
|
(34,645)
|
| Balance at end of period at Mar. 31, 2021 |
|
$ 29
|
2,994,020
|
(435,146)
|
2,558,903
|
| Balance at beginning of period at Dec. 31, 2020 |
|
29
|
3,004,433
|
(400,501)
|
2,603,961
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net income (loss) |
$ (59,700)
|
|
|
|
|
| Balance at end of period at Jun. 30, 2021 |
|
$ 29
|
2,998,516
|
(460,201)
|
2,538,344
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Common stock, shares issued (in shares) |
|
290,793,000
|
|
|
|
| Balance at beginning of period at Mar. 31, 2021 |
|
$ 29
|
2,994,020
|
(435,146)
|
2,558,903
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Restricted stock forfeited (in shares) |
|
(7,000)
|
|
|
|
| Stock Issued During Period, Value, Stock Options Exercised |
|
|
15
|
|
15
|
| Option exercises (in shares) |
|
15,000
|
|
|
|
| Stock-based compensation - equity awards |
|
|
4,481
|
|
4,481
|
| Net income (loss) |
$ (25,055)
|
|
|
(25,055)
|
(25,055)
|
| Balance at end of period at Jun. 30, 2021 |
|
$ 29
|
2,998,516
|
(460,201)
|
2,538,344
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Common stock, shares issued (in shares) |
|
290,801,000
|
|
|
|
| Common stock, shares issued (in shares) |
294,260,623
|
294,261,000
|
|
|
|
| Balance at beginning of period at Dec. 31, 2021 |
|
$ 29
|
3,013,017
|
(262,326)
|
2,750,720
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Restricted stock issued (in shares) |
|
20,000
|
|
|
|
| Restricted stock forfeited (in shares) |
|
(52,000)
|
|
|
|
| Restricted stock used for tax withholding (in shares) |
|
(150,000)
|
|
|
|
| Restricted stock used for tax withholding |
|
|
(1,259)
|
|
(1,259)
|
| Stock Issued During Period, Value, Stock Options Exercised |
|
|
1
|
|
1
|
| Option exercises (in shares) |
|
3,000
|
|
|
|
| Issuance of Common Stock under Employee Stock Purchase Plan |
|
53,000
|
|
|
|
| Issuance of Common Stock under Employee Stock Purchase Plan |
|
|
268
|
|
268
|
| Stock-based compensation - equity awards |
|
|
5,545
|
|
5,545
|
| Net income (loss) |
|
|
|
15,802
|
15,802
|
| Balance at end of period at Mar. 31, 2022 |
|
$ 29
|
3,017,572
|
(246,524)
|
2,771,077
|
| Balance at beginning of period at Dec. 31, 2021 |
|
29
|
3,013,017
|
(262,326)
|
2,750,720
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Option exercises (in shares) |
4,000
|
|
|
|
|
| Net income (loss) |
$ 207,628
|
|
|
|
|
| Common shares outstanding at end of period (in shares) at Jun. 30, 2022 |
284,992,650
|
|
|
|
|
| Balance at end of period at Jun. 30, 2022 |
|
$ 30
|
3,024,236
|
(54,698)
|
2,969,568
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Common stock, shares issued (in shares) |
|
294,135,000
|
|
|
|
| Balance at beginning of period at Mar. 31, 2022 |
|
$ 29
|
3,017,572
|
(246,524)
|
2,771,077
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Restricted stock issued (in shares) |
|
2,998,000
|
|
|
|
| Restricted stock forfeited (in shares) |
|
(75,000)
|
|
|
|
| Stock Issued During Period, Value, Stock Options Exercised |
|
|
7
|
|
7
|
| Option exercises (in shares) |
|
2,000
|
|
|
|
| Stock-based compensation - equity awards |
|
|
6,657
|
|
6,657
|
| Stock Issued During Period, Value, Restricted Stock Award, Gross |
|
$ 1
|
0
|
|
|
| Net income (loss) |
$ 191,826
|
|
|
191,826
|
191,826
|
| Common shares outstanding at end of period (in shares) at Jun. 30, 2022 |
284,992,650
|
|
|
|
|
| Balance at end of period at Jun. 30, 2022 |
|
$ 30
|
$ 3,024,236
|
$ (54,698)
|
$ 2,969,568
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Common stock, shares issued (in shares) |
297,060,327
|
297,060,000
|
|
|
|